Search research articles
Contact Us
Filters
Showing results (661-670 of 1,009) with videos related to
Page
of 101
Sort By:
Bone Research
|
February 18, 2022
Estrogen-mediated downregulation of HIF-1α signaling in B lymphocytes influences postmenopausal bone loss
Xianyi Meng, Zhen Lin, Shan Cao, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
May 16, 2024
Unveiling Metabolic Similarities of Entheses in Patients with Psoriasis and Psoriatic Arthritis Using Noninvasive In Vivo Molecular Imaging: Results From a Cross-sectional Exploratory Study
Filippo Fagni, Koray Tascilar, Rita Noversa de Sousa, et al.
RMD Open
|
February 25, 2026
Long-term osteoprotective effects of IL-17A blockade with secukinumab in psoriatic arthritis: data from the PSARTROS-II study
Louis Schuster, Alp Temiz, Melek Yalcin Mutlu, et al.
Annals of the Rheumatic Diseases
|
November 29, 2011
IgG4 immune response in Churg-Strauss syndrome
Augusto Vaglio, Johanna D Strehl, Bernhard Manger, et al.
Arthritis Research & Therapy
|
September 7, 2021
Accuracy and usability of a diagnostic decision support system in the diagnosis of three representative rheumatic diseases: a randomized controlled trial among medical students
Johannes Knitza, Koray Tascilar, Eva Gruber, et al.
Annals of the Rheumatic Diseases
|
August 24, 2012
Inhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosis
Marlene Krämer, Clara Dees, Jingang Huang, et al.
Annals of the Rheumatic Diseases
|
October 23, 2024
Imaging mass cytometry-based characterisation of fibroblast subsets and their cellular niches in systemic sclerosis
Aleix Rius Rigau, Minrui Liang, Veda Devakumar, et al.
Annals of the Rheumatic Diseases
|
May 8, 2012
Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY)
Maxime Dougados, Karsten Kissel, Tom Sheeran, et al.
Annals of the Rheumatic Diseases
|
May 6, 2016
WNT16 antagonises excessive canonical WNT activation and protects cartilage in osteoarthritis
Giovanna Nalesso, Bethan Lynne Thomas, Joanna Claire Sherwood, et al.
Rheumatology (Oxford, England)
|
October 19, 2017
Remission in psoriatic arthritis-where are we now?
Laura C Coates, Philip G Conaghan, Maria Antonietta D'Agostino, et al.
Page
of 101
Search research articles
Search
Showing results (661-670 of 1,009) with videos related to
Sort By:
Page
of 101
Bone Research
|
February 18, 2022
Estrogen-mediated downregulation of HIF-1α signaling in B lymphocytes influences postmenopausal bone loss
Xianyi Meng, Zhen Lin, Shan Cao, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
May 16, 2024
Unveiling Metabolic Similarities of Entheses in Patients with Psoriasis and Psoriatic Arthritis Using Noninvasive In Vivo Molecular Imaging: Results From a Cross-sectional Exploratory Study
Filippo Fagni, Koray Tascilar, Rita Noversa de Sousa, et al.
RMD Open
|
February 25, 2026
Long-term osteoprotective effects of IL-17A blockade with secukinumab in psoriatic arthritis: data from the PSARTROS-II study
Louis Schuster, Alp Temiz, Melek Yalcin Mutlu, et al.
Annals of the Rheumatic Diseases
|
November 29, 2011
IgG4 immune response in Churg-Strauss syndrome
Augusto Vaglio, Johanna D Strehl, Bernhard Manger, et al.
Arthritis Research & Therapy
|
September 7, 2021
Accuracy and usability of a diagnostic decision support system in the diagnosis of three representative rheumatic diseases: a randomized controlled trial among medical students
Johannes Knitza, Koray Tascilar, Eva Gruber, et al.
Annals of the Rheumatic Diseases
|
August 24, 2012
Inhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosis
Marlene Krämer, Clara Dees, Jingang Huang, et al.
Annals of the Rheumatic Diseases
|
October 23, 2024
Imaging mass cytometry-based characterisation of fibroblast subsets and their cellular niches in systemic sclerosis
Aleix Rius Rigau, Minrui Liang, Veda Devakumar, et al.
Annals of the Rheumatic Diseases
|
May 8, 2012
Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY)
Maxime Dougados, Karsten Kissel, Tom Sheeran, et al.
Annals of the Rheumatic Diseases
|
May 6, 2016
WNT16 antagonises excessive canonical WNT activation and protects cartilage in osteoarthritis
Giovanna Nalesso, Bethan Lynne Thomas, Joanna Claire Sherwood, et al.
Rheumatology (Oxford, England)
|
October 19, 2017
Remission in psoriatic arthritis-where are we now?
Laura C Coates, Philip G Conaghan, Maria Antonietta D'Agostino, et al.
Page
of 101